Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 371, Issue 1, 2005, Pages 1-8

  Ahmad, Shagufta ^a   Fowler, Leslie J ^a   Whitton, Peter S ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

5 Hydroxytryptamine; Amino acids; Dopamine; Hippocampus; Lamotrigine; Microdialysis; Valproate

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; DOPAMINE; GLUTAMIC ACID; LAMOTRIGINE; SEROTONIN; TAURINE; VALPROIC ACID; VERATRIDINE;

4 AMINOBUTYRIC ACID RELEASE; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIALYSATE LEVEL; DOPAMINE RELEASE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DIALYSABILITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG POTENTIATION; HIPPOCAMPUS; MALE; MICRODIALYSIS; MONOAMINE RELEASE; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN SECRETION; RAT; SEROTONIN RELEASE;

ANIMALS; ANTICONVULSANTS; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; DRUG INTERACTIONS; EXTRACELLULAR SPACE; HIPPOCAMPUS; MALE; MICRODIALYSIS; NEUROTRANSMITTER AGENTS; RATS; RATS, WISTAR; TRIAZINES; VALPROIC ACID; VERATRIDINE;

EID: 15044362005     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-1008-4     Document Type: Article

References (48)

1. 3H]aspartate from mouse cerebral cortical slices. Neurochem Res 24:1153-1159
2. + evoked amino acid release in the ventral hippocampus of the rat in vivo. Br Pharmacol Soc 115:116P
3. Ahmad S, Fowler LJ, Whitton PS (2004a) Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. Br J Pharmacol 142:136-142
4. Ahmad S, Fowler LJ, Whitton PS (2004b) Effect of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats. Brain Res 1029:41-47
5. Bazil CW (2002) New antiepileptic drugs. Neurology 8:71-81
6. Biggs CS, Pearce BR, Fowler LJ, Whitton PS (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine and their metabolites in rat brain: an in vivo microdialysis study. J Neurochem 59:1702-1706
7. Biggs CS, Pearce BR, Fowler LJ, Whitton PS (1994) The effect of isonicotinic acid hydrazide on extracellular amino acids and convulsions in the rat: reversal of neurochemical and behavioural deficits by sodium valproate. J Neurochem 63:2197-2201
8. Braga MF, Aroniadou-Anderjaska V, Post RM, Li H (2002) Lamotrigine reduces spontaneous and evoked GABAA receptor-mediated synaptic transmission in the basolateral amygdala: implications for its effects in seizure and affective disorders. Neuropharmacology 42:522-529
9. Cuadrado A, De La Cuevas I, Valdizan EM, Armijo JA (2002) Synergistic interaction between valproate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice. Eur J Pharmacol 453:43-52
10. Cuadrado A, Bravo J, Armijo JA (2003) Synergistic interaction between felbamate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice. Eur J Pharmacol 465:43-52
11. Cunningham MO, Jones RSG (2000) The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vivo. Neuropharmacology 39:2139-2141
12. Dailey JW, Yan Q-S, Adams-Curtis L, Ryu JR, Ko KH, Mishra PK, Jobe PC (1996) Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci 58:259-266
13. Deckers CLP, Genton P, Sills GJ, Schmidt D (2003) Current limitations of antiepileptic drug therapy: a conference review. Epilepsy Res 53:1-17
14. Della Paschoa OE, Kruk MR, Hamstra R, Voskuyl RA, Danhof M (1998a) Pharmacodynamic interaction between phenytoin and sodium valproate changes seizure thresholds and pattern. Br J Pharmacol 125:997-1004
15. Della Paschoa OE, Voskuyl RA, Danhof M (1998b) Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate. Br J Pharmacol 125:1610-1616
16. De Sarro G, Nava F, Aguglia U, De Sarro A (1996) Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Neuropharmacology 35:153-158
17. Esclapez M, Hirsch JC, Ben-Ari Y, Bernard C (1999) Newly formed excitatory pathways for hyperexcitability in experimental temporal lobe epilepsy. J Comp Neurol 408:449-460
18. Ferraro G, Vella N, Sardo P, Caravaglios G, Sabatino M, LaGrutta V (1991) Dopaminergic control of feline hippocampal epilepsy: a nigrohippocampal pathway. Neurosci Lett 123:41-44
19. Ferrie CD, Panayiotopoulos CP (1994) Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy. Seizure 3:157-159
20. Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP (1995) Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand 91:200-202
21. Gervasi N, Monnier Z, Vinvent P, Paupardin-Tritsch D, Hughes SW, Crunelli V, Leresche N (2003) Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures. J Neurosci 23:11469-11478
22. Gidal BE, Anderson GE, Rutecki PR, Shaw R, Lanning A (2000) Lack of an effect of valproate on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy. Epilepsy Res 42:22-31
23. 1A receptor activation. Eur J Pharmacol 380:R1-R3
24. Kanner AM, Frey M (2000) Adding valproate to lamotrigine: a study of their pharmacokinetic interaction. Neurology 22:588-591
25. Kimura M, Tanaka N, Kimura Y, Miyake K, Kitaura T, Fukuchi H (1992) Pharmacokinetic interaction of zonisamide in rats. J Pharmacobiodyn 15:631-639
26. Kwan P, Sills GJ, Brodie MJ (2001) The mechanism of action of commonly used antiepileptic drugs. Pharmacol Ther 90:21-34
27. Lees G, Leach MJ (1993) Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamactil) using primary neurological cultures from rat cortex. Brain Res 612:190-199
28. Levy RH, Bourgeois BFD (1997) Drug-drug interactions. In: Engel J, Pedley TA (eds) Epilepsy: a comprehensive textbook. Lippincott-Raven, Philadelphia, pp 1175-1179
29. Lolin YI, Ratnaraj N, Hjelm, M, Patsalos PN (1994) Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: phenytoin. Epilepsy Res 19:99-110
30. Morris RG, Black AB, Lam E, Westley IS (2000) Clinical study of lamotrigine and valproic acid in patients with epilepsy: using a drug interaction to advantage? Ther Drug Monit 22:656-660
31. Okada M, Hirano T, Mizuno K, Chiba T, Kawata Y, Kiryu K, Wada K, Tasaki H, Kaneko S (1997) Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus. Epilepsy Res 28:143-153
32. Panayiotopoulos GP, Ferrie CD, Knott C, Robinson RO (1993) Interaction of lamotrigine with sodium valproate. Lancet 341:445
33. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic, New York
34. Petroff OAC, Rothmann DL, Behar KL, Hyder F, Mattson RH (1999) Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures. Seizure 8:120-127
35. Pisani F, Di Perri R, Perucca E, Richens A (1993) Interaction of lamotrigine with sodium valproate. Lancet 341:1224
36. Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A (1999) The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 40:1141-1146
37. Reife RA (1998) Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs. Adv Neurol 76:95-103
38. Rowley HL, Marsden CA, Martin KF (1995) Differential effects of phenytoin and sodium valproate on seizure-induced changes in gamma-aminobutyric acid and glutamate release in vivo. Eur J Pharmacol 294:541-546
39. Smolders I, Van Belle K, Ebinge G, Michotte Y (1997) Hippocampal and cerebellar extracellular amino acids during pilocarpine-induced seizures in freely moving rats. Eur J Pharmacol 319:21-29
40. 1A receptor binding in patients with temporal lobe epilepsy. Neurology 60:749-756
41. Waldmeier PC, Baumann PA, Wick P, Feldtrauer JJ, Stierlin C, Scmutz M (1995) Similar potency of carbamazepine, oxcarbazepine and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 45:1907-1913
42. Waldmeier PC, Martin P, Stocklin K, Portet C, Scmutz M (1996) Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum. Naunyn-Schmiedebergs Arch Pharmacol 354:164-172
43. Wang SJ, Sibra TS, Gean PW (2001) Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. Neuroreport 12:2255-2258
44. Whitton PS, Fowler LJ (1991) The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo. Eur J Pharmacol 200:167-169
45. Whitton PS, Oreskovic D, Jernej B, Bulat M (1984) Antiepileptic di-n-propylacetamide and di-H-propylacetic acid increase the noradrenaline turnover in the brain. Period Biol 86:231-234
46. Whitton PS, Biggs CS, Pearce BR, Fowler LJ (1992) MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum. J Neurochem 58:1573-1575
47. + channel expressed in a stable mammalian cell line. Pflugers Arch 441:425-433
48. Yerby MS (2003) Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology 61:S23-S36